Use of a Novel Synbiotic to Change Human Gut Bacteria and Improve Health in Obese Adults

NACompletedINTERVENTIONAL
Enrollment

151

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

August 31, 2015

Study Completion Date

October 31, 2015

Conditions
Intestinal Microbiota and Barrier Function
Interventions
DIETARY_SUPPLEMENT

Bifidobacteria adolescentis BD1

packet containing 10\^9 cells of Bifidobacteria adolescentis BD1

DIETARY_SUPPLEMENT

Bifidobacteria animalis subsp. lactis BB-12

packet containing 10\^9 cells of Bifidobacteria animalis subsp. lactis BB-12

DIETARY_SUPPLEMENT

Bifidobacteria adolescentis BD1 and galactooligosaccharide

packet containing 10\^9 cells Bifidobacteria adolescentis BD1 and 5 g galactooligosaccharide

DIETARY_SUPPLEMENT

Bifidobacteria animalis subsp. lactis BB-12 and galactooligosaccharide

packet containing 10\^9 cells B animalis subsp. lactis BB-12 and 5 g galactooligosaccharide

DIETARY_SUPPLEMENT

galactooligosaccharide

5 g galactooligosaccharide

DIETARY_SUPPLEMENT

Placebo

lactose powder, 5 grams

Trial Locations (1)

60612

Rush University Medical Center, Chicago

All Listed Sponsors
collaborator

University of Nebraska Lincoln

OTHER

collaborator

University of Alberta

OTHER

lead

Rush University Medical Center

OTHER

NCT02355210 - Use of a Novel Synbiotic to Change Human Gut Bacteria and Improve Health in Obese Adults | Biotech Hunter | Biotech Hunter